Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Harmon

Showing results (241-250 of 292) with videos related to

Pageof 30
Sort By:
Oncotarget|February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesionStephanie A Harmon, Esther Mena, Joanna H Shih, et al.
Abdominal Radiology (New York)|July 3, 2024
Deep learning-based image quality assessment: impact on detection accuracy of prostate cancer extraprostatic extension on MRIYue Lin, Mason J Belue, Enis C Yilmaz, et al.
Intensive Care Medicine|June 30, 2018
Increasing evidence-based interventions in patients with acute infections in a resource-limited setting: a before-and-after feasibility trial in Gitwe, RwandaOlivier Urayeneza, Pierre Mujyarugamba, Zacharie Rukemba, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrenceAnson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate CancerStephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
Critical Care Medicine|June 30, 2018
Increasing Evidence-Based Interventions in Patients with Acute Infections in a Resource-Limited Setting: A Before-and-After Feasibility Trial in Gitwe, RwandaOlivier Urayeneza, Pierre Mujyarugamba, Zacharie Rukemba, et al.
Academic Radiology|March 8, 2020
Quality of Prostate MRI: Is the PI-RADS Standard Sufficient?Jonathan Sackett, Joanna H Shih, Sarah E Reese, et al.
The Journal of Urology|July 28, 2020
PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active SurveillanceAlex Z Wang, Luke P O’Conno, Nitin K Yerram, et al.
The Journal of Urology|December 28, 2020
Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate CancerNitin K Yerram, Lori Long, Luke P O'Connor, et al.
European Urology Open Science|March 12, 2024
Evaluating Diagnostic Accuracy and Inter-reader Agreement of the Prostate Imaging After Focal Ablation Scoring SystemDavid G Gelikman, Alexander P Kenigsberg, Yan Mee Law, et al.
Pageof 30

Showing results (241-250 of 292) with videos related to

Sort By:
Pageof 30
Oncotarget|February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesionStephanie A Harmon, Esther Mena, Joanna H Shih, et al.
Abdominal Radiology (New York)|July 3, 2024
Deep learning-based image quality assessment: impact on detection accuracy of prostate cancer extraprostatic extension on MRIYue Lin, Mason J Belue, Enis C Yilmaz, et al.
Intensive Care Medicine|June 30, 2018
Increasing evidence-based interventions in patients with acute infections in a resource-limited setting: a before-and-after feasibility trial in Gitwe, RwandaOlivier Urayeneza, Pierre Mujyarugamba, Zacharie Rukemba, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrenceAnson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate CancerStephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
Critical Care Medicine|June 30, 2018
Increasing Evidence-Based Interventions in Patients with Acute Infections in a Resource-Limited Setting: A Before-and-After Feasibility Trial in Gitwe, RwandaOlivier Urayeneza, Pierre Mujyarugamba, Zacharie Rukemba, et al.
Academic Radiology|March 8, 2020
Quality of Prostate MRI: Is the PI-RADS Standard Sufficient?Jonathan Sackett, Joanna H Shih, Sarah E Reese, et al.
The Journal of Urology|July 28, 2020
PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active SurveillanceAlex Z Wang, Luke P O’Conno, Nitin K Yerram, et al.
The Journal of Urology|December 28, 2020
Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate CancerNitin K Yerram, Lori Long, Luke P O'Connor, et al.
European Urology Open Science|March 12, 2024
Evaluating Diagnostic Accuracy and Inter-reader Agreement of the Prostate Imaging After Focal Ablation Scoring SystemDavid G Gelikman, Alexander P Kenigsberg, Yan Mee Law, et al.
Pageof 30